A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2006
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247246 3-{[(5,5a,8a,9)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl]amino}-1-methyl-1H-pyrrole-2,5-dione; anticarcinogenic agent; inhibiting catalytic activity of topoisomerase II by stabilization of cleavable complex; better soluble and tolerated
11/02/2006	US20060247237 Macrocyclic quinazoline derivatives as antiproliferative agents
11/02/2006	US20060247232 Heterocyclic compound and antitumor agent containing the same as effective ingredient
11/02/2006	US20060247221 Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
11/02/2006	US20060247210 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247186 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
11/02/2006	US20060247185 Stabilization of amrubicin hydrochloride
11/02/2006	US20060246586 Chromosome-based platforms
11/02/2006	US20060246538 Capable of sodium-independently transporting branched amino acids
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246433 Method and nucleic acids for the analysis of a colon cell proliferative disorder
11/02/2006	US20060246153 Herbal compositions for the teatment and prevention of prostate disorders
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246077 Use of antibodies against the MUC18 antigen
11/02/2006	US20060246042 Cells, culture methods, and their use in autologous transplantation therapy
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	EP1717251A2 Methods of therapy for B-cell malignancies using human anti-CD40 antibodies
11/02/2006	EP1717248A1 Tumor targeted vector
11/02/2006	EP1717245A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006	EP1717244A1 Akt activity specifically inhibiting polypeptide
11/02/2006	EP1717229A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1716858A2 Oncolytic virus
11/02/2006	EP1716857A1 Composition for nkt cell activation
11/02/2006	EP1716853A2 Treatment of cancers of the human body using ET743
11/02/2006	EP1716852A1 A composition comprising campothecin or a campothecin derivative and an alkylating agent for the treatment of cancer
11/02/2006	EP1716180A2 Anti-ube4a/ufd2b polyclonal antibody and its use thereof as diagnostic and prognostic marker of 11q23 region alterations
11/02/2006	EP1716178A1 Less immunogenic binding molecules
11/02/2006	EP1716173A2 Carcinoembryonic antigen fusion protein and uses thereof
11/02/2006	EP1716167A1 Cell surface marker
11/02/2006	EP1716155A1 Substituted thieno¬2,3-d\|pyrimidines as inhibitors of tie2
11/02/2006	EP1716149A2 Method for the production of crystalline (6rs)-n(5)-formyl-5,6,7,8-tetrahydrofolic acid
11/02/2006	EP1716119A1 Analogs of benzoquinone-containing ansamycins for the treatment of cancer
11/02/2006	EP1715896A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer
11/02/2006	EP1715895A2 Chemically-modified human growth hormone receptor antagonist conjugates
11/02/2006	EP1715892A2 Methods and compositions for modulating angiogenesis
11/02/2006	EP1715864A1 Use of siramesine in the treatment of cancer
11/02/2006	EP1633352B1 Polyene oxazoles with antitumour activity and processes for their preparation using a streptomyces strain
11/02/2006	EP1585744B1 Process for making ondansetron and intermediates thereof
11/02/2006	EP1501565B1 Compounds and method for coating surfaces in a haemocompatible manner
11/02/2006	EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1401801B1 Selective androgen receptor modulators and methods of use thereof
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1387689B1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof
11/02/2006	EP1276760B1 Polyamide nucleic acid derivatives, agents and methods for producing them
11/02/2006	EP1261629B1 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids
11/02/2006	EP1180035B1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1-alpha, 25-DIHYDROXY VITAMIN D3
11/02/2006	EP1105157B1 Protein delivery system using human papillomavirus virus-like particles
11/02/2006	EP1102604B1 Drug releasing elastic band
11/02/2006	EP1058686B1 2'-fluoronucleosides
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0823908B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
11/02/2006	CA2814247A1 Polymorphic and amorphous salt forms of squalamine dilactate
11/02/2006	CA2609927A1 Methods and means for the treatment of hpv induced intraepithelial neoplasias
11/02/2006	CA2607455A1 Antibodies with immune effector activity and that internalize in endosialin-positive cells
11/02/2006	CA2607444A1 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
11/02/2006	CA2606399A1 Use of compounds to enhance processivity of telomerase
11/02/2006	CA2606088A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006	CA2606077A1 Polymorphic and amorphous salt forms of squalamine dilactate
11/02/2006	CA2605796A1 Pharmaceutical compositions and methods comprising a combination of a selective estrogen receptor modulator and an aromatase inhibitor
11/02/2006	CA2605756A1 New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
11/02/2006	CA2605745A1 Cancer specific pcna isoform binding antibodies and uses thereof
11/02/2006	CA2605744A1 Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
11/02/2006	CA2605669A1 Method for treating advanced ovarian cancer with doxorubicin entrapped in liposomes
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2604284A1 Protein kinase inhibitors
11/02/2006	CA2571710A1 Small molecule immunopotentiators and assays for their detection
11/01/2006	CN1856498A Thienopyridine and furopyridine kinase inhibitors
11/01/2006	CN1856486A Substituted lactams and their use as anti-cancer agents
11/01/2006	CN1856469A Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
11/01/2006	CN1856326A Combinations of a VEGF receptor inhibitor with other therapeutic agents
11/01/2006	CN1856323A Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
11/01/2006	CN1856322A Microsome vaccine
11/01/2006	CN1856313A Therapeutic compounds
11/01/2006	CN1856311A 6-aryl-7-halo-imidazo[1,2-A]pyrimidines as anticancer agents
11/01/2006	CN1856302A Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir)
11/01/2006	CN1854313A Method for diagnosing non-small cell lung cancers
11/01/2006	CN1854157A Antibodies to insulin-like growth factor i receptor
11/01/2006	CN1854130A Chinazoline derivative, its production, medicinal composition and use
11/01/2006	CN1854125A Aryl-group-substituted acrylonitrile compound, its production and use
11/01/2006	CN1853730A Modified cytokines for use in cancer therapy
11/01/2006	CN1853726A Polymer system for improving insoluble medicine water solubility and preparation thereof
11/01/2006	CN1853723A Combinational therapy involving a small molecule inhibitor of the MDM2: p53 interaction
11/01/2006	CN1853718A Positioning composition for oral liquid and its preparation
11/01/2006	CN1853700A Use of fritillaria alkaloid extract in preparation of medicine for treating tumor
11/01/2006	CN1853694A Medicinal composition for treating leukemia
11/01/2006	CN1853651A Medicinal composition containing cinnabar or/and realgar
11/01/2006	CN1853645A Combined preparations comprising morpholine anthracyclines and anticancer agent
11/01/2006	CN1853642A Combined preparations comprising morpholine anthracyclines and anticancer agent
11/01/2006	CN1853627A Cyclodextrin of bibenziisosehenazole ethane or cyclodextrin derivative inclusion compound, and preparation and use thereof
11/01/2006	CN1853623A Use of hellebore alkaloid in tumor treatment
11/01/2006	CN1282649C Corter pseudolaricis acid derivatives, preparation method and use thereof
11/01/2006	CN1282636C Vitamin D analogues
11/01/2006	CN1282485C Dendron shaped cell tumour vaccine for loading withered heat shock tumour cell, its preparation method and application
11/01/2006	CN1282466C Preparation extracted from stephania tetrandra S. Moor and the use thereof
11/01/2006	CN1282452C Use of aminoadamantane compound as immunoregulators
10/2006
10/31/2006	US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions

1 ... 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 ... 2211